Close

Mr Martin Harker

Research Fellow - Health Economics of TB

United Kingdom

I am a health economist and infectious disease modeller. I undertook my undergraduate studies at University of Cambridge in mathematics and natural sciences, focussing on genetics. After work for the medical aid agency Merlin, I studied for an MSc in Public Health (Health Economics) at LSHTM. I have subsequently worked as a health economist for more than ten years, initially on UK projects and more recently concentrating on global health.

During six years at the National Guideline Centre at the Royal College of Physicians, I worked on clinical guidelines for the National Institute for Health and Care Excellence (NICE), helping to set UK health policy on areas including cardiac and liver disease, pancreatitis, hearing loss and prison healthcare. I conducted economic modelling leading to new recommendations on questions such as statins and hearing aid availability.

I have also work at the Centre for Health Economics, University of York, where I co-wrote a report on global health policy prioritisation and conducted clinical trial data analysis. Most recently I led the health economic work for the TB-Speed programme, investigating strategies to increase diagnosis of tuberculosis in children.

Affiliations

Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Teaching

I am a tutor for some seminars on the Economic Evaluation module. I have also tutored on Health Economic Modelling short courses.

Research

I am studying for a PhD in the TB Modelling Group. I am investigating the effectiveness and cost effectiveness of preventive therapies for drug-resistant TB, focussing on South Africa.

I am co-lead for the Infectious Diseases theme of the Global Health Economics Centre (GHECO) at LSHTM.

I am interested in the interaction of disease modelling and economic modelling methods, and in decision-making processes for resource prioritisation.
Research Area
Health economics
Mathematical modelling
Infectious disease policy
Disease and Health Conditions
Tuberculosis
Infectious diseases
Country
South Africa
United Kingdom
Cambodia
Cote d'Ivoire
Sierra Leone
Mozambique
Uganda
Zambia
Cameroon
Region
Sub-Saharan Africa (all income levels)
World

Selected Publications

Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.
FULLER, NM; MCQUAID, CF; HARKER, MJ; Weerasuriya, CK; McHugh, TD; KNIGHT, GM;
2024
PLoS pathogens
Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study.
D'Elbée, M; HARKER, M; Mafirakureva, N; Nanfuka, M; Huyen Ton Nu Nguyet, M; Taguebue, J-V; Moh, R; Khosa, C; Mustapha, A; Mwanga-Amumpere, J; Borand, L; Nolna, SK; Komena, E; Cumbe, S; Mugisha, J; Natukunda, N; Mao, TE; Wittwer, J; Bénard, A; Bernard, T; Sohn, H; Bonnet, M; Wobudeya, E; Marcy, O; Dodd, PJ; ... TB-Speed Health Economics Study Group,
2024
EClinicalMedicine
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods Manual.
ANGELIS, A; HARKER, M; CAIRNS, J; Seo, MK; LEGOOD, R; Miners, A; WISEMAN, V; Chalkidou, K; GRIEVE, R; BRIGGS, A;
2023
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Hearing loss in adults, assessment and management: summary of NICE guidance.
Ftouh, S; Harrop-Griffiths, K; HARKER, M; Munro, KJ; Leverton, T; Guideline Committee,;
2018
BMJ (Clinical research ed.)
Diagnosis and management of drug allergy in adults, children and young people: summary of NICE guidance.
Dworzynski, K; Ardern-Jones, M; Nasser, S; Guideline Development Group,; National Institute for Health and Care Excellence,;
2014
BMJ (Clinical research ed.)
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
Rabar, S; HARKER, M; O'Flynn, N; Wierzbicki, AS; Guideline Development Group,;
2014
BMJ (Clinical research ed.)
Key recommendations and evidence from the NICE guideline for the acute management of ST-segment-elevation myocardial infarction.
HARKER, M; Carville, S; Henderson, R; Gray, H; Guideline Development Group,;
2013
Heart (British Cardiac Society)
Acute management of myocardial infarction with ST-segment elevation: summary of NICE guidance.
Carville, S; HARKER, M; Henderson, R; Gray, H; Guideline Development Group,;
2013
BMJ (Clinical research ed.)
See more information